Pure Global

Increasing Equity in Lung Cancer Screening - Trial NCT06360822

Access comprehensive clinical trial information for NCT06360822 through Pure Global AI's free database. This phase not specified trial is sponsored by Indiana University and is currently Recruiting. The study focuses on Lung Cancer. Target enrollment is 144 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06360822
Recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06360822
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Increasing Equity in Lung Cancer Screening

Study Focus

Lung Cancer

ED-LCS

Interventional

behavioral

Sponsor & Location

Indiana University

Indianapolis, United States of America

Timeline & Enrollment

N/A

Dec 01, 2023

Feb 01, 2027

144 participants

Primary Outcome

Rate of patients receive Lung Cancer Screening

Summary

The overall objective of this mixed methods study is to: 1) Refine the Emergency Department
 Lung Cancer Screening (ED-LCS) intervention using qualitative interviews among key
 stakeholders; 2) pilot test the ED-LCS intervention evaluating the intervention efficacy,
 acceptability, and feasibility; and 3) provide an in-depth description of stakeholders'
 experiences with the ED-LCS intervention for future refinement.

ICD-10 Classifications

Carcinoma in situ: Bronchus and lung
Secondary malignant neoplasm of lung
Malignant neoplasm of bronchus and lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm: Overlapping lesion of bronchus and lung

Data Source

ClinicalTrials.gov

NCT06360822

Non-Device Trial